Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie C Crockett

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Design, Development and Therapy|June 29, 2013
Osteoporosis - a current view of pharmacological prevention and treatmentSubhajit Das, Julie C Crockett
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Transfection of osteoclasts and osteoclast precursorsJulie C Crockett, David J Mellis, Adam Taylor
Calcified Tissue International|October 6, 2011
Absence of glutamine supplementation prevents differentiation of murine calvarial osteoblasts to a mineralizing phenotypePhilip M Brown, James D Hutchison, Julie C Crockett
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Isolation and purification of rabbit osteoclastsFraser P Coxon, Michael J Rogers, Julie C Crockett
The Journal of Endocrinology|September 10, 2011
The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorptionDavid J Mellis, Cecile Itzstein, Miep H Helfrich, et al.
Biochimica Et Biophysica Acta|December 27, 2013
Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cellsSubhajit Das, Peter A Edwards, Julie C Crockett, et al.
Bone|November 30, 2010
Biochemical and molecular mechanisms of action of bisphosphonatesMichael J Rogers, Julie C Crockett, Fraser P Coxon, et al.
Molecular Pharmacology|February 28, 2006
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosisKeith Thompson, Michael J Rogers, Fraser P Coxon, et al.
Calcified Tissue International|November 6, 2007
A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivoAlun Hughes, Michael J Rogers, Aymen I Idris, et al.
British Journal of Pharmacology|April 18, 2009
Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitroJohanna Räikkönen, Julie C Crockett, Michael J Rogers, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Design, Development and Therapy|June 29, 2013
Osteoporosis - a current view of pharmacological prevention and treatmentSubhajit Das, Julie C Crockett
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Transfection of osteoclasts and osteoclast precursorsJulie C Crockett, David J Mellis, Adam Taylor
Calcified Tissue International|October 6, 2011
Absence of glutamine supplementation prevents differentiation of murine calvarial osteoblasts to a mineralizing phenotypePhilip M Brown, James D Hutchison, Julie C Crockett
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Isolation and purification of rabbit osteoclastsFraser P Coxon, Michael J Rogers, Julie C Crockett
The Journal of Endocrinology|September 10, 2011
The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorptionDavid J Mellis, Cecile Itzstein, Miep H Helfrich, et al.
Biochimica Et Biophysica Acta|December 27, 2013
Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cellsSubhajit Das, Peter A Edwards, Julie C Crockett, et al.
Bone|November 30, 2010
Biochemical and molecular mechanisms of action of bisphosphonatesMichael J Rogers, Julie C Crockett, Fraser P Coxon, et al.
Molecular Pharmacology|February 28, 2006
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosisKeith Thompson, Michael J Rogers, Fraser P Coxon, et al.
Calcified Tissue International|November 6, 2007
A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivoAlun Hughes, Michael J Rogers, Aymen I Idris, et al.
British Journal of Pharmacology|April 18, 2009
Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitroJohanna Räikkönen, Julie C Crockett, Michael J Rogers, et al.
Pageof 2